Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameABBOTT AXSYM HAVAB 2.0
Classification Namehepatitis a test (antibody and igm antibody)
Generic Nameantibody to hepatitis a virus 125i (human)
Regulation Number866.3310
ApplicantABBOTT LABORATORIES
PMA NumberP780012
Supplement NumberS009
Date Received06/09/2000
Decision Date02/02/2004
Product Code
LOL[ Registered Establishments with LOL ]
Advisory Committee Microbiology
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the abbott axsym havab 2. 0. The device, as modified, will be marketed under the trade name abbott axsym havab 2. 0 and is indicated for the qualitative detection of total antibody to hepatitis a virus (anti-hav) in human serum or plasma. A test for anti-hav is indicated as an aid in the diagnosis of previous or ongoing hepatitis a viral infection or in the identification of hav-susceptible individuals for vaccination.
-
-